MeSH Browser

MeSH Heading: Bufexamac
Tree Number(s): D02.065.064.294.088; D02.092.570.394.150; D02.241.511.372.150; D02.455.426.559.389.048.088
Unique ID: D002019
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D002019
Scope Note: A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
Entry Term(s): Allergipuran; Bufal; Bufederm; Bufexamac-ratiopharm; Droxaryl; Jomax; Malipuran; Paraderm; Parfenac; Windol; duradermal; p-Butoxyphenylacethydroxamic Acid
Pharm Action: Anti-Inflammatory Agents, Non-Steroidal
Related Numbers: 2438-72-4
CAS Type 1 Name: Benzeneacetamide, 4-butoxy-N-hydroxy-
Previous Indexing: Hydroxamic Acids (1971-1974); Phenylacetates (1971-1974)
Public MeSH Note: 91; was see under HYDROXAMIC ACIDS 1975-90
History Note: 91(75); was see under HYDROXAMIC ACIDS 1975-90
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2016/07/05

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Bufexamac MeSH Descriptor Data 2024